Global Pharmaceutical Packaging Market, By Product (Primary Packaging, Secondary and Tertiary Packaging), Material (Plastics & Polymers, Paper and Paperboards, Glass, Metals, and Others), Drug Delivery Mode (Oral Drug Delivery Packaging, Parenteral Drug Delivery Packaging, Topical Drug Delivery Packaging, Inhalation Drug Delivery Packaging, Nasal Drug Delivery Packaging, Ocular Drug Delivery Packaging, Other Drugs Delivery Packaging), End User (Pharma Manufacturing Companies, Contract Packaging Companies, Pharmacies, and Others) - Industry Trends and Forecast to 2031 .
Pharmaceutical Packaging Market Analysis and Insights
Outsourcing contract packaging services has become crucial for pharmaceutical companies, enabling them to focus on core competencies while meeting demanding standards. Prespack offers multidimensional partnerships, relieving manufacturers of medicinal products or medical devices from many processes. This trend reflects the growing pharmaceutical outsourcing sector, ultimately contributing to the expansion of the pharmaceutical packaging market.
Data Bridge Market Research analyzes that the global pharmaceutical packaging market is expected to reach USD 192.66 billion by 2031 from USD 111.52 billion in 2023, growing at a CAGR of 7.2% in the forecast period of 2024 to 2031.
|
Report Metric
|
Details
|
|
Forecast Period
|
2024 to 2031
|
|
Base Year
|
2023
|
|
Historic Years
|
2022 (Customizable to 2016–2021)
|
|
Quantitative Units
|
Revenue in USD Billion
|
|
Segments Covered
|
Product (Primary Packaging, Secondary and Tertiary Packaging), Material (Plastics & Polymers, Paper and Paperboards, Glass, Metals, and Others), Drug Delivery Mode (Oral Drug Delivery Packaging, Parenteral Drug Delivery Packaging, Topical Drug Delivery Packaging, Inhalation Drug Delivery Packaging, Nasal Drug Delivery Packaging, Ocular Drug Delivery Packaging, Other Drugs Delivery Packaging), End User (Pharma Manufacturing Companies, Contract Packaging Companies, Pharmacies, and Others)
|
|
Countries Covered
|
U.S., Canada, Mexico, Germany, U.K., France, Italy, Netherlands, Spain, Russia, Switzerland, Turkey, Belgium, Rest of Europe, China, Japan, India, South Korea, Australia, Singapore, Indonesia, Thailand, Malaysia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, U.A.E., Saudi Arabia, Egypt, Israel, Rest of Middle East and Africa
|
|
Market Players Covered
|
WestRock Company, Amcor plc, BD, AptarGroup, Inc., West Pharmaceutical Services, Inc., Berry Global , Inc., CCL Industries, Gerresheimer AG, Schott AG, UFlex Limited, SGD Pharma, EPL Limited, Drug Plastics Group, Comar, and Daikyo Seiko Co., Ltd., among others
|
Market Definition
Pharmaceutical packaging involves the process of enclosing medications and other pharmaceutical products in packaging materials that ensure their protection, identification, and information dissemination. These materials include plastics, glass, aluminum, paper, and cardboard, each chosen for its specific properties and application. These materials are carefully selected based on their compatibility with the pharmaceutical product, their ability to protect against external factors, and regulatory requirements.
Global Pharmaceutical Packaging Market Dynamics
This section deals with understanding the market drivers, opportunities, restraints, and challenges. All of this is discussed in detail below:
Drivers
- Rising Pharmaceutical Outsourcing
Pharmaceutical companies are increasingly opting to outsource manufacturing processes to specialized contract packagers. This strategic shift allows these companies to concentrate on their core competencies such as research, development, and marketing, while leaving the complexities of packaging to experts. Contract packagers offer a range of services including packaging design, materials selection, and ensuring compliance with stringent regulatory requirements. This is particularly advantageous for pharmaceutical firms seeking innovative and customized packaging solutions for their products.
- Evolving Role of Pharmaceutical Packaging in Market Differentiation
Packaging has evolved beyond its traditional role of merely containing pharmaceutical products; it is now a key element in differentiating these products in the market. This shift is driven by the intensifying competition in the pharmaceutical industry, where companies are leveraging packaging as a tool to set their products apart from competitors. Packaging serves as a visual and informational platform that communicates vital details about the product, including its quality, safety, and efficacy. Additionally, packaging acts as a marketing medium, helping to attract consumers and influence their purchasing decisions. In response to this trend, there has been a surge in innovative packaging solutions. For example, smart packaging incorporates digital features like RFID tags or QR codes, enabling consumers to access additional product information or track authenticity.
The use of eco-friendly materials in packaging is gaining traction, reflecting consumers' growing environmental consciousness. These innovative approaches not only differentiate products but also contribute to sustainable practices, further enhancing brand reputation.
The focus on product differentiation through packaging is driving significant advancements in the pharmaceutical packaging industry, fostering a market environment ripe for continuous innovation and improvement.
Opportunity
- Innovations in Smart Packaging
Innovations in smart packaging, such as temperature-sensitive labels and RFID tracking, are revolutionizing the global pharmaceutical packaging market. These advancements offer a myriad of benefits, starting with enhanced visibility across the supply chain. Temperature-sensitive labels, for instance, provide real-time monitoring, ensuring medications are stored and transported under optimal conditions. This capability is particularly crucial for pharmaceuticals, as maintaining the right temperature is critical for preserving their efficacy and safety. Moreover, RFID tracking enables companies to track individual product units, ensuring authenticity and preventing tampering. This level of traceability not only helps in compliance with regulatory standards but also boosts consumer trust. Additionally, smart packaging facilitates efficient recall processes, as companies can quickly identify and retrieve affected products.
Restraints/Challenges
- Counterfeiting and Product Security
Counterfeiting in the pharmaceutical sector poses a multifaceted challenge despite the advancements in packaging technologies. The proliferation of counterfeit drugs not only jeopardizes patient health but also erodes trust in pharmaceutical products and the industry. These illicit activities often involve sophisticated tactics, including the replication of packaging and labeling to mimic genuine products. As counterfeiters continually evolve their methods to evade detection, pharmaceutical companies must remain vigilant and adapt their packaging strategies to stay ahead of these threats. This ongoing battle against counterfeit drugs underscores the critical importance of innovative packaging solutions and collaborative efforts within the industry and regulatory bodies to ensure the safety and integrity of pharmaceutical products.
- Cost Constraints for Implementing Advanced Packaging Technologies
The development and implementation of advanced packaging technologies, such as smart packaging and anti-counterfeiting measures, often require substantial investment in research, development, and technology infrastructure. For smaller companies with limited resources, these costs can be prohibitive, preventing them from adopting innovative packaging solutions. As a result, these companies may be at a disadvantage compared to larger competitors who can afford to invest in advanced packaging technologies. This constraint hinder the overall growth and innovation potential of the pharmaceutical packaging market, limiting the availability of advanced packaging solutions and potentially hindering market competitiveness.
Recent Developments
- In September 2023, WestRock Company WRK and Smurfit Kappa Group Plc SMFKY have agreed to merge and create Smurfit WestRock, which is expected to be one of the world’s largest paper and packaging company with a worth of around $20 billion
- In July 2023, Constantia Flexibles has announced its latest pharmaceutical packaging solution, the coldform foil REGULA CIRC, a cutting-edge technology that sets a new standard for sustainability in blister packaging. Designed with circularity in mind, REGULA CIRC complies with future regulations and legislation, offering a total barrier solution that meets the highest sustainable packaging standards
- In June 2022, Berlin Packaging, a one of world's largest hybrid packaging supplier, announced the acquisition of Andler Packaging Group, a value-added distributor of plastic, glass, and metal containers and closures
- In December 2021, Comar, a premier supplier of custom medical devices and assemblies and specialty packaging solutions, announced today it has acquired Omega Packaging, a manufacturer of injection and blow molded products serving the pharmaceutical, nutraceutical, sports nutrition, and skin care markets
- In April 2022, Amcor, a leader in the design and production of ethical packaging solutions, recently revealed the addition of a new, more environment-friendly High Shield laminate to its line of pharmaceutical packaging
Global Pharmaceutical Packaging Market Scope
The global pharmaceuticals packaging market is segmented into four notable segments based on product, material, drug delivery mode, and end user. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the differences in your target markets.
Product
- Primary Packaging
- Secondary and Tertiary Packaging
On the basis of product, the market is segmented into primary packaging, and secondary and tertiary packaging.
Material
- Plastics & Polymers
- Paper and Paperboards
- Glass
- Metals
- Others
On the basis of material, the market is segmented into plastics & polymers, paper and paperboards, glass, metals, and others.
Drug Delivery Mode
- Oral Drug Delivery Packaging
- Parenteral Drug Delivery Packaging
- Topical Drug Delivery Packaging
- Inhalation Drug Delivery Packaging
- Nasal Drug Delivery Packaging
- Ocular Drug Delivery Packaging
- Other Drugs Delivery Packaging
On the basis of drug delivery mode, the market is segmented into oral drug delivery packaging, parenteral drug delivery packaging, topical drug delivery packaging, inhalation drug delivery packaging, nasal drug delivery packaging, ocular drug delivery packaging, and other drugs delivery packaging.
End User
- Pharma Manufacturing Companies
- Contract Packaging Companies
- Pharmacies
- Others
On the basis of end user, the market is segmented into pharma manufacturing companies, contract packaging companies, pharmacies, and others.
Global Pharmaceutical Packaging Market Regional Analysis/Insights
The global pharmaceutical packaging market is categorized into four notable segments based on product, material, drug delivery mode, and end user.
The countries covered in this market report are U.S., Canada, Mexico, Germany, U.K., France, Italy, Netherlands, Spain, Russia, Switzerland, Turkey, Belgium, rest of Europe, China, Japan, India, South Korea, Australia, Singapore, Indonesia, Thailand, Malaysia, Philippines, rest of Asia-Pacific, Brazil, Argentina, rest of South America, South Africa, U.A.E., Saudi Arabia, Egypt, Israel, and rest of Middle East and Africa.
North America is expected to dominate the global pharmaceutical packaging market due to its advanced healthcare infrastructure, robust regulatory framework, and significant investment in research and development. U.S. is expected to dominate the North America due to its advanced healthcare infrastructure, large pharmaceutical industry, and high demand for innovative packaging solutions. China is expected to dominate in the Asia-Pacific region due to its rapidly expanding pharmaceutical industry, large consumer base, and increasing investments in healthcare infrastructure and packaging technologies. Germany is expected to dominate in the Europe region due to its robust pharmaceutical manufacturing sector, strong regulatory environment, and emphasis on high-quality packaging standards.
The country section of the report also provides individual market-impacting factors and changes in regulation in the market domestically that impact the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts, and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands and the impact of sales channels are considered while providing forecast analysis of the country data.
Competitive Landscape and Global Pharmaceutical Packaging Market Share Analysis
The global pharmaceutical packaging market competitive landscape provides details of competitors. Details included are company overview, company financials, revenue generated, market potential, investment in R&D, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product approvals, product width and breadth, application dominance, and product type lifeline curve. The above data points provided are only related to the company’s focus on the market.
Some of the major market players operating in the market are WestRock Company, Amcor plc, BD, AptarGroup, Inc., West Pharmaceutical Services, Inc., Berry Global, Inc., CCL Industries, Gerresheimer AG, Schott AG, UFlex Limited, SGD Pharma, EPL Limited, Drug Plastics Group, Comar, and Daikyo Seiko Co., Ltd., among others.
SKU-